P. Whelton

P. Whelton, Xi-gui Wu, D. Gu, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Geographic variations in the prevalence, awareness, treatment and control of hypertension in China

Jing Chen, Jiang He, Kristi Reynolds, 2003, Journal of hypertension.

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies.

P. Whelton, Jiang He, J. He, 1999, The New England journal of medicine.

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and MortalityA Systematic Review and Network Meta-analysis

P. Whelton, Changwei Li, Jiang He, 2017 .

Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial

P. Whelton, L. Bortolotto, F. Fuchs, 2017, Journal of hypertension.

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease andMortality

Tanika N. Kelly, Jing Chen, Jiang He, 2017 .

Prehypertension and risk of cardiovascular disease in Chinese adults

Daniel W. Jones, P. Whelton, Ji-chun Chen, 2009, Journal of hypertension.

Premature deaths attributable to blood pressure in China: a prospective cohort study

K. Reynolds, P. Whelton, Ji-chun Chen, 2009, The Lancet.

Blood pressure and risk of cardiovascular disease in Chinese men and women.

P. Whelton, Ji-chun Chen, Xi-gui Wu, 2008, American journal of hypertension.

Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults

C. L. Yau, P. Whelton, Ji-chun Chen, 2007, Circulation.

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

B. Davis, Jackson T. Wright, P. Whelton, 2006, Hypertension.

Familial aggregation of renal disease in a population-based case-control study.

P. Whelton, J. Coresh, T. Perneger, 1998, Journal of the American Society of Nephrology : JASN.

Central Rather Than Overall Obesity Is Related to Diabetes in the Chinese Population: The InterASIA Study

P. Whelton, D. Hu, D. Gu, 2007, Obesity.

Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.

N. Cook, P. Whelton, L. Appel, 2016, Journal of the American College of Cardiology.

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension

Barry J. Davis, Jackson T. Wright, P. Whelton, 2007, Diabetes Care.

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, Jackson T. Wright, P. Whelton, 2008, Archives of internal medicine.

Epidemiology and prevention of blood pressure-related renal disease.

P. Whelton, T. Perneger, F. Brancati, 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Chapter 23 – Blood Pressure Reduction

P. Whelton, Jiang He, 2004 .

Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors.

Zheng-lai Wu, P. Whelton, J. He, 1995, Stroke.

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

B. Davis, Jackson T. Wright, P. Whelton, 2009, Archives of internal medicine.

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.

R. Collins, B. Davis, C. Bulpitt, 1998, Journal of hypertension.

Dietary macronutrients and blood pressure in southwestern China

P. Whelton, Jiang He, M. Klag, 1995, Journal of hypertension.

Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.

Jackson T. Wright, P. Whelton, S. Oparil, 2008, Hypertension.

The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications

B. Davis, Jackson T. Wright, P. Whelton, 2018, American journal of hypertension.

Hormonal responses to acute volume changes in anephric subjects.

P. Whelton, W. G. Walker, D. Gann, 1983, Kidney international.

Risk of stroke in male cigarette smokers.

P. Whelton, M. Klag, 1987, The New England journal of medicine.

Weight change and mortality: Long‐term results from the trials of hypertension prevention

N. Cook, P. Whelton, L. Appel, 2018, Journal of clinical hypertension.

The classics: a tribute to the fiftieth anniversary of the randomized clinical trial.

P. Whelton, F. Fuchs, M. Klag, 2000, Journal of clinical epidemiology.

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

P. Whelton, G. Stone, G. Parati, 2022, Circulation.

Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China

K. Reynolds, P. Whelton, Xi-gui Wu, 2004, Circulation.

Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.

N. Powe, P. Whelton, G. de Lissovoy, 1992, JAMA.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Sathish Kumar Jayapal, Alan D. Lopez, Ravi Prakash Jha, 2020, Journal of the American College of Cardiology.

Trends in pharmacologic management of hypertension in the United States.

P. Whelton, J. Cutler, B. Psaty, 1995, Archives of internal medicine.

Community cholesterol screening. Impact of labeling on participant behavior.

P. Whelton, M. Klag, R. Gordon, 1990, Archives of internal medicine.

Reflections on the U.S. preventive services task force recommendations for screening for hypertension and hypercholesterolemia

P. Whelton, 1990, Journal of general internal medicine.

The renin-angiotensin system and blood pressure: differences between blacks and whites.

P. Whelton, L. Appel, J. He, 1999, American journal of hypertension.

Effect of migration and related environmental changes on serum lipid levels in southwestern Chinese men.

Zheng-lai Wu, P. Whelton, J. He, 1996, American journal of epidemiology.

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

Jackson T. Wright, J. Williamson, P. Whelton, 2019, JAMA.

Blood Pressure Effects of Sodium Reduction

P. Whelton, M. Malavolti, M. Vinceti, 2021, Circulation.

2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.

P. Whelton, L. Colantonio, G. Howard, 2018, Journal of the American College of Cardiology.

Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly.

P. Whelton, L. Appel, Zhenzhen Zhang, 2016, American journal of public health.

Salt, Blood Pressure, and Cointervention-Reply

N. Cook, P. Whelton, J. Cutler, 1997 .

Dietary sodium and blood pressure.

P. Whelton, W. Applegate, J. Cohen, 1996, JAMA.

Combinations of potassium, calcium, and magnesium supplements in hypertension.

P. Whelton, N. Borhani, L. Appel, 1995, Hypertension.

Hypertension management in populations.

P. Whelton, F. Brancati, 1993, Clinical and experimental hypertension.

Magnesium and blood pressure: review of the epidemiologic and clinical trial experience.

P. Whelton, M. Klag, P. K. Whelton, 1989, The American journal of cardiology.

Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study

B. Davis, Jackson T. Wright, P. Whelton, 2012, Circulation. Cardiovascular quality and outcomes.

Effect of soy and milk protein supplementation on serum lipid levels: a randomized controlled trial

K. Reynolds, P. Whelton, J. He, 2012, European Journal of Clinical Nutrition.

The Glycemic Consequences of Antihypertensive Medications

B. Davis, P. Whelton, J. Barzilay, 2015 .

The Glycemic Effects of Antihypertensive Medications

B. Davis, P. Whelton, J. Barzilay, 2013, Current Hypertension Reports.

Thiazide-Induced Dysglycemia

Jackson T. Wright, P. Whelton, S. Oparil, 2008 .

Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia.

K. Reynolds, P. Whelton, Xi-gui Wu, 2004, American journal of public health.

The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association.

A. Dominiczak, P. Whelton, S. Oparil, 2017, European heart journal.

Dose–response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study

N. Cook, P. Whelton, J. Cutler, 2005, Journal of Human Hypertension.

Rate of change in body mass index at different ages during childhood and adult obesity risk

P. Whelton, Jiang He, Shengxu Li, 2019, Pediatric obesity.

Hypertension prevalence, awareness, treatment, and control in Egypt: Results from the Egyptian National Hypertension Project (NHP)

P. Whelton, L. Appel, E. Roccella, 1995 .

Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.

P. Whelton, Jiang He, J. He, 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Body mass and blood pressure in a lean population in southwestern China.

P. Whelton, M. Klag, M. Klag, 1994, American journal of epidemiology.

SPRINT Revisited: Updated Results and Implications.

Jackson T. Wright, J. Williamson, P. Whelton, 2021, Hypertension.

Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidel

P. Whelton, J. Cutler, W. Cushman, 2009, Hypertension.

The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence.

P. Whelton, T. Perneger, M. Klag, 1996, Journal of human hypertension.

Potassium in preventing and treating high blood pressure.

P. Whelton, J. He, 1999, Seminars in Nephrology.

Percentage of ingested sodium excreted in 24‐hour urine collections: A systematic review and meta‐analysis

Chelsea T. A. Doktorchik, M. Woodward, P. Whelton, 2018, Journal of clinical hypertension.

Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, P. Whelton, J. Probstfield, 1998, Controlled clinical trials.

Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary

P. López-Jaramillo, P. Whelton, K. Reddy, 2021, Hypertension.

Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy: The Bogalusa Heart Study

Tao Zhang, P. Whelton, Jiang He, 2018, Hypertension.

Metabolic Syndrome and Salt-Sensitivity of Blood Pressure among Persons without Diabetes

P. Whelton, T. Rice, Ji-chun Chen, 2010 .

Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study

P. Whelton, T. Rice, Ji-chun Chen, 2009, The Lancet.

Erratum: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys. 1960-1991 (Hypertension (1995) 26 (60-69))

P. Whelton, J. Cutler, D. Labarthe, 1996 .

Cause of death in patients with end-stage renal disease: death certificates vs registry reports.

P. Whelton, T. Perneger, M. Klag, 1993, American journal of public health.

Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial

P. Whelton, Xi-gui Wu, D. Gu, 2001, Journal of hypertension.

End-Stage Renal Disease Attributable to Diabetes Mellitus

P. Whelton, T. Perneger, F. Brancati, 1994, Annals of Internal Medicine.

End-stage Renal Disease in African-American and White Men

P. Whelton, J. Neaton, J. Stamler, 2016 .

Effectiveness of the Waksberg telephone sampling method for the selection of population controls.

P. Whelton, T. Perneger, M. Klag, 1993, American journal of epidemiology.

Diagnosis of hypertensive end-stage renal disease: effect of patient's race.

P. Whelton, T. Perneger, M. Klag, 1995, American journal of epidemiology.

Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

P. Whelton, J. Lee, J. Kusek, 1996, Controlled clinical trials.

Effect of Dietary Protein Supplementation on Blood Pressure

Daniel W. Jones, K. Reynolds, P. Whelton, 2011 .

Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial.

Daniel W. Jones, K. Reynolds, P. Whelton, 2011, Circulation.

Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial.

Daniel W. Jones, K. Reynolds, P. Whelton, 2011, Circulation.

Hypertension in diabetes mellitus.

P. Whelton, 2009, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

Hypertension in diabetes mellitus.

P. Whelton, 2009, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

Projections of hypertension-related renal disease in middle-aged residents of the United States.

T V Perneger, P. Whelton, T. Perneger, 1993, JAMA.

Effect of Blood Pressure on Early Decline in Kidney Function Among Hypertensive Men

P. Whelton, J. Lefante, Jiang He, 2003, Hypertension.

Blood pressure and end-stage renal disease in men.

P. Whelton, J. Neaton, J. Stamler, 1996, The New England journal of medicine.

Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion

P. Whelton, D. Beevers, S. Sonkodi, 2004, Journal of Human Hypertension.

Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9.

B. Davis, P. Whelton, Mahboob Rahman, 2006, American journal of hypertension.

The Egyptian National Hypertension Project (NHP). Design and rationale. The NHP Investigative Team.

P. Whelton, L. Appel, M. Ibrahim, 1995, Hypertension.

Detection, Treatment and Control of Hypertension in the General Population

P. Whelton, Jiang He, P. Muntner, 2005 .

End-stage renal disease in African-American and white men. 16-year MRFIT findings.

P. Whelton, J. Neaton, J. Stamler, 1997, JAMA.

Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.

P. Whelton, J. Lee, J. Kusek, 1996, Controlled clinical trials.

Hypertension in Chronic Renal Failure

P. Whelton, P. Russell, 1983 .

Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.

Jiang He, Lee Hamm, P. Whelton, 2002, Journal of the American Society of Nephrology : JASN.

ORIGINAL INVESTIGATIONS Creatinine Clearance as a Measure of GFR in Screenees for the African-American Study of Kidney Disease and Hypertension Pilot Study

P. Whelton, J. Coresh, F. V. Lente, 1998 .

Age-specific prevalence and factors associated with normal blood pressure among US adults.

Byron C. Jaeger, K. Reynolds, P. Whelton, 2021, American journal of hypertension.

Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.

P. Whelton, M. Rocco, Mahboob Rahman, 2020, JAMA internal medicine.

Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians

Byron C. Jaeger, P. Whelton, G. Howard, 2019, Hypertension.

Prevalence of cardiovascular risk factors in South Korean adults: results from the Korea Medical Insurance Corporation (KMIC) Study.

P. Whelton, L. Appel, S. Jee, 1998, Annals of epidemiology.

[2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the AmericasDiretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na região das Américas

P. Whelton, E. Roccella, V. Irazola, 2022, Revista panamericana de salud publica = Pan American journal of public health.

Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League

P. Whelton, D. Lackland, P. Ordunez, 2018, Journal of clinical hypertension.

2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

V. Feigin, P. Whelton, G. Parati, 2022, Journal of Human Hypertension.

Blood pressure targets.

P. Whelton, M. Krousel-Wood, Jing Chen, 2017, European heart journal.